Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 5, 2009, Pages 353-355

  Xavier, Melissa Orzechowski ^a   Pasqualotto, Alessandro Comarú ^b,c   Aquino, Valério Rodrigues ^a,d   Sukiennik, Teresa Cristina Teixeira ^b   Severo, Luiz Carlos ^a,b,c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Santa Casa Complexo Hospitalar   (Brazil)

^c Brazilian government ^*  (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Aspergillosis; Galactomannan; Piperacillin tazobactam; Platelia aspergillus

Indexed keywords

GALACTOMANNAN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MANNAN; PENICILLANIC ACID; PIPERACILLIN;

ARTICLE; ASPERGILLUS; BRAZIL; CARBOHYDRATE ANALYSIS; COMMERCIAL PHENOMENA; CONTROLLED STUDY; CROSS REACTION; DRUG MARKETING; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; LABORATORY; PILOT STUDY; SERUM; CHEMISTRY; EVALUATION; IMMUNOLOGY; LABORATORY DIAGNOSIS;

ANTI-BACTERIAL AGENTS; ASPERGILLUS; FALSE POSITIVE REACTIONS; IMMUNOENZYME TECHNIQUES; MANNANS; PENICILLANIC ACID; PIPERACILLIN;

EID: 77953714270     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000500007     Document Type: Article

References (17)

1. De Pauw B., Walsh T.J., Donnelly J.P. et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
2. Aquino V., Goldani L.Z., Pasqualotto A.C. Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia 2007; 163: 191-02.
3. st 2008.
4. st 2008.
5. Bart-Delabesse E., Basile M., Jijakli A.A. et al. Detection of Aspergillus Galactomannan Antigenemia To Determine Biological and Clinical Implications of Beta-Lactam Treatments. J Clin Microbiol 2005; 43: 5214-20.
6. Aubry A., Porcher R., Bottero J. et al. Occurrence and Kinetics of False-Positive Aspergillus Galactomannan Test Results following Treatment with ß-Lactam Antibiotics in Patients with Hematological Disorders. J Clin Microbiol 2006; 44: 389-94.
7. Alhambra A., Cuétara M.S., Oetiz M.C. et al. False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam. Rev Iberoam Micol 2007; 24: 106-12.
8. Walsh T.J., Shoham S., Petraitiene R. et al. Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In vitro, In vivo, and Clinical Properties of the Drug-Antigen Interaction. J Clin Microbiol 2004; 42: 4744-8.
9. Machetti M., Furfaro E., Viscoli C. Galactomannan in Piperacillin-Tazobactam: How Much and to What Extent? Antimicrob Agents Chemother 2005; 49: 3984-5.
10. Singh N., Obman A., Husain S. et al. Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum. Antimicrob Agents Chemother 2004; 48: 1989-92.
11. Machetti M., Majabo M.J., Furfaro E. et al. Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis. J Antimicrob Chemother 2006; 58: 806-10.
12. Orlopp K., von Lilienfeld-Toal M., Marklein G. et al. False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem? J Antimicrob Chemother 2008; 62: 1109-12.
13. Penack O., Rempf P., Graf B. et al. False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam -is it still an issue? Diag Microbiol Infect Dis 2008; 60: 117-20.
14. Penack O., Schwartz S., Thiel E., Wolfgang Blau I. Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clin Infect Dis 2004; 39: 1401-2.
15. Ozkalemkas F., Ozcelik T., Ozkocaman V. Treatment with piperacillin-tazobactam and Aspergillus galactomannan test results for patients with hematological malignancies. Eur J Intern Med 2007; 18: 79.
16. Alhambra A., Cuétara M.S., Ortiz M.C. et al. False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam. Rev Iberoam Micol 2007; 24: 106-12.
17. Viscoli C., Machetti M., Cappellano P. et al. False-positive galactomannan Platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38: 913-6.